Skip to main content
NTLA
NASDAQ Life Sciences

Intellia Secures $400M Non-Dilutive Debt Facility with OrbiMed

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$12.8
Mkt Cap
$1.777B
52W Low
$7.95
52W High
$28.25
52W Position info
61% above low
Off High info
55% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NTLA sits 61% above its 52-week low of $7.95.

Summary

Intellia has secured a $400 million non-dilutive senior secured term loan facility with OrbiMed, with $75 million funded upfront and the remainder tied to milestones. This financing extends the company's cash runway without shareholder dilution, supporting the planned U.S. approval and commercial launch of lonvo-z for hereditary angioedema. The deal follows positive Phase 3 results for lonvo-z reported in June and Q2 2026 financials that extended cash runway into 2028. The non-dilutive structure is a positive signal, as it avoids equity issuance at current depressed prices. Key watch items include achievement of the milestones required to access the additional $225 million in tranches and the FDA decision on lonvo-z.

At the time of this announcement, NTLA was trading at $12.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $7.95 to $28.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NTLA - Latest Insights

NTLA
Nov 12, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.60
Real-time Price: $10.13 info
Change: -$0.475 (-4%) info
Market Cap: $1.411B info
NTLA
Nov 12, 2026, 10:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.72
Real-time Price: $10.13 info
Change: -$0.595 (-6%) info
Market Cap: $1.411B info
NTLA
Nov 05, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $10.13 info
Change: -$2.18 (-18%) info
Market Cap: $1.411B info
NTLA
Sep 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.74
Real-time Price: $10.13 info
Change: -$2.62 (-21%) info
Market Cap: $1.411B info
NTLA
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $13.69
Real-time Price: $10.13 info
Change: -$3.56 (-26%) info
Market Cap: $1.411B info